Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.3%

6 terminated/withdrawn out of 58 trials

Success Rate

83.8%

-2.7% vs industry average

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

0%

0 of 31 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
43(84.3%)
Phase 3
2(3.9%)
Early Phase 1
2(3.9%)
Phase 2
2(3.9%)
Phase 1
1(2.0%)
Phase 4
1(2.0%)
51Total
N/A(43)
Phase 3(2)
Early Phase 1(2)
Phase 2(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (58)

Showing 20 of 58 trials
NCT07243743Not ApplicableCompleted

Assessment of the Glycemic Responses to Nutritional Products-INQ-2526

Role: lead

NCT06475521Not ApplicableEnrolling By Invitation

A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and follow-on Formula for Healthy Term Infants.

Role: lead

NCT07324135Not ApplicableNot Yet Recruiting

Effect of Young Child Formula on Iron Status in Children 1-3 Years of Age.

Role: lead

NCT07243730Not ApplicableRecruiting

Amino Acids in the Blood After Eating Yoghurt and Milk Proteins

Role: lead

NCT05474105Not ApplicableCompleted

Multi-Nutrient Supplementation as a Therapeutic Intervention in Ischaemic Stroke

Role: collaborator

NCT07207109Not ApplicableNot Yet Recruiting

Effect of follow-on Formula on the Gut Microbiota of Healthy Infants.

Role: lead

NCT06781619Not ApplicableRecruiting

Effect of Plant Based High Energy High Protein Oral Nutritional Supplement on Nutritional Intake in Patients With or at Risk of Disease Related Malnutrition.

Role: lead

NCT07086573Not ApplicableNot Yet Recruiting

The Effect of Algae Oil Supplements on Functional Immune Response and Bioavailability of Lipids in Blood, a Pilot Study

Role: collaborator

NCT05618704Not ApplicableCompleted

Growth, Safety and Tolerance of a Hydrolyzed Protein Infant Formula

Role: lead

NCT06797349Phase 4Completed

Glin4: Assessment of the Glycemic Responses to Nutritional Products

Role: lead

NCT06920550Recruiting

A Growth Artificial Intelligence Algorithm for leNgth and Weight Study

Role: lead

NCT06628024Not ApplicableCompleted

Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk.

Role: lead

NCT05495360Not ApplicableCompleted

Effect of Omega 3 Enriched Oral Nutritional Supplement on Nutritional Status of CRC and NSCLC Patients

Role: lead

NCT05453838Not ApplicableCompleted

Bioequivalence of a Diabetes Specific Tube Feed

Role: lead

NCT03807310Not ApplicableRecruiting

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)

Role: collaborator

NCT06645171Not ApplicableNot Yet Recruiting

Effect of an Oral Nutritional Supplement (ONS) with Prebiotic Fibre Compared to a Non-fibre Containing ONS Equal in Energy and Protein Content on Gut Microbiota in Older Adults with or At Risk of Disease Related Malnutrition

Role: lead

NCT06645184Not ApplicableNot Yet Recruiting

Adding Appetite Stimulants to an ONS in Older Adults

Role: lead

NCT03315221Phase 2Completed

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.

Role: lead

NCT06057415Not ApplicableRecruiting

Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System

Role: collaborator

NCT06215534Not ApplicableCompleted

Glin3: Assessment of the Glycemic Responses to Nutritional Products

Role: lead